Development of New Psychopharmacological Agents for Depression and Anxiety
- PMID: 26300029
- DOI: 10.1016/j.psc.2015.05.009
Development of New Psychopharmacological Agents for Depression and Anxiety
Abstract
Antidepressant and anxiolytic drug development has largely stalled. This article reviews novel current programs for developing depressants and anxiolytics. Biological bases are discussed for these, as are recent results. Problems encountered are reviewed. Recently announced failed programs for other antidepressants are then discussed with an eye toward uncovering possible common elements that may explain their failures. Lastly, possible solutions for improving the likelihood of the success of antidepressant/anxiolytic agents are discussed.
Keywords: Antidepressants; Anxiolytics; Glucocorticoid antagonists; Glutamatergic agents; Ketamine; Mu-opioid agents; NMDA antagonists; Obotulinum toxin.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
[Chronobiological similarity of the specific activity of anxiolytic and antidepressant drugs].Eksp Klin Farmakol. 2007 Sep-Oct;70(5):52-8. Eksp Klin Farmakol. 2007. PMID: 18074809 Review. Russian.
-
Ketamine: A Paradigm Shift for Depression Research and Treatment.Neuron. 2019 Mar 6;101(5):774-778. doi: 10.1016/j.neuron.2019.02.005. Neuron. 2019. PMID: 30844397 Free PMC article. Review.
-
[The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].Nihon Shinkei Seishin Yakurigaku Zasshi. 2012 Aug;32(4):219-26. Nihon Shinkei Seishin Yakurigaku Zasshi. 2012. PMID: 23012890 Review. Japanese.
-
Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.Brain Res. 2015 Mar 19;1601:117-26. doi: 10.1016/j.brainres.2015.01.001. Epub 2015 Jan 8. Brain Res. 2015. PMID: 25578259
-
Modelling the anxiety-depression continuum in chicks.J Psychopharmacol. 2009 Mar;23(2):143-56. doi: 10.1177/0269881108089805. Epub 2008 May 30. J Psychopharmacol. 2009. PMID: 18515452
Cited by
-
Hormonal Treatments for Major Depressive Disorder: State of the Art.Am J Psychiatry. 2020 Aug 1;177(8):686-705. doi: 10.1176/appi.ajp.2020.19080848. Epub 2020 May 27. Am J Psychiatry. 2020. PMID: 32456504 Free PMC article. Review.
-
Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance.Phytother Res. 2018 May;32(5):865-891. doi: 10.1002/ptr.6033. Epub 2018 Feb 21. Phytother Res. 2018. PMID: 29464801 Free PMC article.
-
Overexpression of microRNA-301b accelerates hippocampal microglia activation and cognitive impairment in mice with depressive-like behavior through the NF-κB signaling pathway.Cell Death Dis. 2019 Apr 8;10(4):316. doi: 10.1038/s41419-019-1522-4. Cell Death Dis. 2019. PMID: 30962417 Free PMC article.
-
Rutin Improves Anxiety and Reserpine-Induced Depression in Rats.Molecules. 2022 Oct 27;27(21):7313. doi: 10.3390/molecules27217313. Molecules. 2022. PMID: 36364141 Free PMC article.
-
Neural Signaling of Cortisol, Childhood Emotional Abuse, and Depression-Related Memory Bias.Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Mar;3(3):274-284. doi: 10.1016/j.bpsc.2017.11.005. Epub 2017 Nov 22. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018. PMID: 29486869 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
